Inhibrx Biosciences, Inc.
Recent Filings
All 114 filings →| Form | Description | Date |
|---|---|---|
| 8-K | 8-K | Mar 19, 2026 |
| 10-K | 10-K | Mar 19, 2026 |
| 8-K | 8-K | Feb 23, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G | — | Jan 21, 2026 |
| 8-K | 8-K | Dec 16, 2025 |
| 8-K | 8-K | Nov 14, 2025 |
| 10-Q | 10-Q | Nov 14, 2025 |
| 8-K | 8-K | Oct 23, 2025 |
| SCHEDULE 13G/A | — | Oct 17, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Viking Global Opportunities Parent GP LLC | — | Sale | 25,042 @ $32.25 | 102,864 | Oct 7, 2025 |
| Kayyem Jon Faiz | — | Purchase | 34,843 @ $14.23 | 51,093 | Nov 19, 2024 |
| Vuori Kristiina MD | — | Purchase | 6,667 @ $15.00 | 20,443 | Oct 3, 2024 |
| Lappe Mark | Chief Executive Officer | Purchase | 26,963 @ $15.05 | 692,511 | Sep 16, 2024 |
| Lappe Mark | Chief Executive Officer | Purchase | 26,000 @ $15.29 | 647,548 | Sep 10, 2024 |
| Vuori Kristiina MD | — | Purchase | 6,457 @ $15.07 | 13,776 | Sep 10, 2024 |
| Lappe Mark | Chief Executive Officer | Purchase | 10,000 @ $14.03 | 135,000 | Sep 3, 2024 |
| Vuori Kristiina MD | — | Purchase | 7,140 @ $14.00 | 7,140 | Aug 29, 2024 |
| MANHARD KIMBERLY | — | Purchase | 10,000 @ $13.98 | 10,000 | Aug 28, 2024 |
| FORSYTH DOUGLAS | — | Purchase | 59,812 @ $14.07 | 224,564 | Aug 22, 2024 |